Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Public Health.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Impact of kidney function on biomarkers of neurodegeneration, white matter hyperintensities, and cognition in older adults.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

The Social Vulnerability Index and Incidence of Alzheimer Disease in a Population-Based Sample of Older Adults.

Neurology·2025
Same author

Cardiovascular Health and Biomarkers of Neurodegenerative Disease in Older Adults.

JAMA network open·2025
Same author

Blood Pressure Variability and Cognition in Black and White Older Adults Over 18 Years of Follow-up: A Population-Based Cohort Study.

Neurology·2024
Same author

Circulating adipokines and MRI markers of brain aging in middle-aged adults from the community.

Journal of Alzheimer's disease : JAD·2024
Same journal

Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Estimated labor market outcomes of people progressing from preclinical to early-stage Alzheimer's disease in the United States.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Amyloid exacerbates tau and alpha-synuclein pathologies, behavioral impairments, and neuroinflammation in a mixed dementia model.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Anisa Dhana1, Charles Decarli2, Klodian Dhana1

  • 1Rush University Medical Center, Chicago, IL, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
PubMed
概括
此摘要是机器生成的。

功能受损与较高水平的神经退行生物标志物有关,如神经丝光 (NfL),总 (t-tau) 和状纤维酸性蛋白 (GFAP). 功能没有影响认知衰退率,但影响生物标志物测量.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经学 神经学
  • 腎臟病學 (nephrology) 是一種醫學.
  • 生物标志物研究 生物标志物研究

背景情况:

  • 神经退行生物标志物 (NfL,t-tau,GFAP) 与认知能力下降和阿尔茨海默病风险有关.
  • 这些生物标志物的血清水平可能会在功能减弱的个体中升高,不管他们的认知状况如何.

研究的目的:

  • 检查功能和血清神经退行生物标志物之间的关联.
  • 确定功能障碍是否影响NfL,GFAP和t-tau与纵向认知变化之间的关系.

主要方法:

  • 来自芝加哥健康与衰老项目的1207名老年人的分析.
  • 通过估计的质过率 (eGFRcr) 评估功能;分类为正常,受损或严重.
  • 血清生物标志物用基于珠的免疫试验测量;全球认知通过认知测试评估.

主要成果:

  • 较低的eGFRcr与较高的NfL,GFAP和t-tau血清水平相关.
  • 与正常功能的人相比,功能受损和严重的个体表现出明显更高的NfL水平.
  • 功能没有改变这些生物标志物与认知衰退率之间的关联.

结论:

  • 功能受损可以影响神经退行生物标志物的血清水平.
  • 在NfL,GFAP和t-tau的研究和临床使用中,应考虑估计的淋巴膜过率 (eGFRcr).